A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders
Clinical trial NCT04516278 · COMPLETED
Trial details
- NCT number
- NCT04516278
- Sponsor
- Outlook Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2021-02-10
- Enrollment
- 197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.